Test Price
2,800 AED✅ Home Collection Available
KCNH1 Gene Temple-Baraitser Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين KCNH1 لمتلازمة تمبل-بارايتسر بتقنية التسلسل الجيني من الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✅ 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing
🏠 VIP Mobile Phlebotomy & Hospital-Grade Cold-Chain Home Collection (8 AM – 11 PM)
🧬 Free Post-Test Clinical Guidance by DHA-Licensed Genetic Consultants
📋 Direct Insurance Billing Verification via WhatsApp
ملخص تنفيذي: فحص جيني طبي دقيق لتشخيص متلازمة تمبل-بارايتسر النادرة. يستند إلى أحدث إرشادات هيئة الصحة بدبي 2026 مع ضمان الامتثال القانوني الكامل بموجب المرسوم الاتحادي رقم 41 لسنة 2024 وقانون البيانات الصحية. تقدم الخدمة للمقيمين في الإمارات إمكانية السحب المنزلي المعقم مع استشارة وراثية هاتفية موثوقة.
Clinical Overview: KCNH1 Gene Sequencing for Temple-Baraitser Syndrome
This advanced Next-Generation Sequencing (NGS) test analyses the entire coding region of the KCNH1 gene, the only gene known to cause Temple-Baraitser syndrome—a rare dysmorphology condition marked by intellectual disability, epilepsy, and distinct facial features. In the UAE, this 2800 AED test is exclusively offered through our DHA/MOHAP-licensed genetic laboratory, utilising targeted panel sequencing with 99.9% analytical sensitivity and a 3–4 week turnaround.
| Feature | Our Test (KCNH1 NGS Premium) | Standard Hospital Genetic Panel |
|---|---|---|
| Methodology | Targeted NGS with full exon coverage & 1000× read depth | Often limited to Sanger sequencing (single exon) or low-coverage NGS |
| Clinical Reporting | DHA-certified interpretation with 2026 ICD-10 coding & pedigree analysis | Raw result only; may lack correlation to dysmorphology findings |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| Pre-Test Genetic Counselling | Included (pedigree charting & family screening discussion) | Often not provided or limited to a brief note |
Physician Insight & Safety Protocol
“As a Senior Consultant Geneticist (DHA 61713011), I emphasise that this test identifies pathogenic variants in KCNH1 with high precision, but a negative result does not exclude other genetic aetiologies or a clinical diagnosis of Temple-Baraitser syndrome. All results must be correlated with a comprehensive dysmorphology evaluation and family history. I urge all patients and families to discuss findings with a clinical geneticist before making any medical or lifestyle decisions.” — Dr. Prabhakar Reddy, DHA-Licensed Consultant Geneticist
⚠️ Medication Warning & Safety Exclusion Criteria
Do not discontinue any prescribed antiepileptic, psychotropic, or other medications before this test. Abrupt withdrawal can trigger serious adverse events.
- Exclusion Criteria: The test cannot be performed on patients who have received a whole blood transfusion within the last 2 weeks, or on samples that are improperly collected and not transported at 2–8°C.
- Red Flags – Seek Immediate Medical Attention: If the patient experiences a sudden increase in seizures, loss of consciousness, or signs of stroke following blood draw, go to the nearest emergency department.
- Consent & Minors: In compliance with UAE CDS Law 2026, testing of minors requires written consent from the legal guardian, supported by clinical justification and pre-test genetic counselling.
Frequently Asked Questions
What is the KCNH1 Genetic Test and why is it needed?
Direct Answer: This test analyses the KCNH1 gene using Next-Generation Sequencing to confirm a diagnosis of Temple-Baraitser syndrome in patients with characteristic dysmorphic features, developmental delay, and epilepsy. (يبحث هذا التحليل عن الطفرات في جين KCNH1 لتأكيد متلازمة تمبل-بارايتسر لدى المرضى الذين يعانون من سمات وجهية مميزة وتأخر في النمو ونوبات صرع.)
How is the sample collected and how long do results take?
Direct Answer: A small blood sample (or one drop on an FTA card) is collected at home by a DHA-licensed phlebotomist between 8 AM and 11 PM; results are delivered securely within 3 to 4 weeks. (تُسحب عينة دم صغيرة في المنزل بواسطة فني معتمد من هيئة الصحة بدبي، وتصدر النتائج خلال 3 إلى 4 أسابيع مع استشارة وراثية مجانية.)
Is this test covered by UAE insurance and how is privacy protected?
Direct Answer: We provide direct insurance billing verification via WhatsApp; all genetic data is encrypted and handled in strict compliance with UAE PDPL and Federal Decree-Law No. 41 of 2024. (نوفر خدمة التحقق المباشر من التغطية التأمينية عبر الواتساب، ونضمن الامتثال الكامل لقانون حماية البيانات الشخصية الإماراتي والمرسوم الاتحادي رقم 41 لسنة 2024.)
UAE Legal & Quality Compliance
- ✅ Licensed by DHA/MOHAP – Facility License No. 9834453
- ✅ ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
- ✅ Strict adherence to Federal Decree-Law No. 41 of 2024 on genetic testing (Art. 87: consent, counselling, and reporting standards)
- ✅ CDS Law 2026: special provisions for minors and vulnerable populations
- ✅ UAE Personal Data Protection Law (PDPL) – all patient data encrypted and stored within UAE borders
- ✅ Pre- information: Clinical history documentation and genetic counselling session with pedigree charting are mandated before sample collection.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians